Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Tekcapital portfolio company Belluscura to raise US$603,000

Tekcapital said that proceeds of the private placement will be used for further investment in Belluscura’s products in development
Tekcapital said this private placement was priced at US$0.18 per share

Tekcapital PLC (LON:TEK) has announced that its portfolio company Belluscura PLC  has completed a further tranche in the private placement to raise an additional US$603,000 through the issue of equity.

The AIM-listed firm said that following the placement announced on February 14, Belluscrua has converted loans equal to approximately US$78,000 to equity under the same terms as the private placement.

READ: Tekcapital to deliver intellectual property commercialisation programme in Chile

Tekcapital said this private placement was priced at US$0.18 (13p) per share, giving medical equipment specialist Belluscura a post-money valuation of approximately US$4.3mln.

The intellectual property investment group said the private placement will continue to remain open to enable current shareholders and additional investors to participate.

Tekcapital added that proceeds of the private placement will be used for further investment in Belluscura’s products in development, specifically the CURV oxygen concentrator and Snap III level of consciousness monitor, and for general working capital purposes. 

View full TEK profile View Profile

Tekcapital PLC Timeline

August 24 2018

Related Articles

Initial public offering
June 26 2018
The timing and ability of the group to realise its investments in partner companies is subject to inherent uncertainty due to numerous factors. The company is looking to change its business model a bit to become a financial supporter of companies looking to float or execute a trade sale
Big lorry
August 25 2018
"Trains, planes and automobiles" - it's the name of a classic John Hughes film but it might also be a good title for the story of Seeing Machines
Picture of XTEK's products
May 04 2018
Patersons' price target of $1.15 implies upside of 130% relative to XTEK's current share price.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use